Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.

Among nuclear receptors, the androgen receptor (AR) is unique in that its ligand-binding domain (LBD) interacts with the FXXLF motif in the N-terminal domain, resembling coactivator LXXLL motifs. We compared AR- and estrogen receptor alpha-LBD interactions of the wild-type AR FXXLF motif and coactivator transcriptional intermediary factor 2 LXXLL motifs and variants of these motifs. Random mutagenesis revealed a key role for the F residues in FXXLF motifs in high-affinity and selective AR LBD interaction. The FXXLF motif in full-length AR and transcriptional intermediary factor 2 LXXLL motifs competed for an overlapping binding site. A computer model of the AR LBD/AR FXXLF complex showed that the bulky F residues are buried in a deep coactivator-binding groove. The corresponding groove in estrogen receptor alpha LBD is considerably shallower, explaining lack of binding of any of the FXXLF motifs tested. FXXLF and LXXLL motif interaction depended on different charged amino acid residues in the AR LBD present at opposite ends of the coactivator groove. In conclusion, our data demonstrate the importance of a deep hydrophobic groove and alternative usage of charged amino acids in specifying peptide binding to the AR LBD.

[1]  J. Trapman,et al.  Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). , 1998, Molecular endocrinology.

[2]  M. Stallcup,et al.  Role of protein methylation in chromatin remodeling and transcriptional regulation , 2001, Oncogene.

[3]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[4]  F. Dilworth,et al.  Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription , 2001, Oncogene.

[5]  J. Trapman,et al.  Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. , 1997, Biochemistry.

[6]  F. Claessens,et al.  The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1 , 1999, Molecular and Cellular Biology.

[7]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[8]  T. Ikonen,et al.  Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators* , 1997, The Journal of Biological Chemistry.

[9]  R J Fletterick,et al.  Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. , 1998, Science.

[10]  F. S. French,et al.  Androgen receptor defects : Historical, clinical, and molecular perspectives , 1995 .

[11]  E. Wilson,et al.  The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators* , 2002, The Journal of Biological Chemistry.

[12]  S. Yeh,et al.  The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs* , 2003, Journal of Biological Chemistry.

[13]  R. Hubbard,et al.  A structural biologist's view of the oestrogen receptor , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  G. Coetzee,et al.  Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins , 1999, Molecular and Cellular Biology.

[15]  Y. Shang,et al.  Formation of the androgen receptor transcription complex. , 2002, Molecular cell.

[16]  J. A. van der Korput,et al.  The human androgen receptor: domain structure, genomic organization and regulation of expression. , 1989, Journal of steroid biochemistry.

[17]  J. Trapman,et al.  Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor. , 2002, European journal of biochemistry.

[18]  D. Gardner,et al.  Coactivator-Vitamin D Receptor Interactions Mediate Inhibition of the Atrial Natriuretic Peptide Promoter* , 2000, The Journal of Biological Chemistry.

[19]  L. Chiche,et al.  Substitution of Ala564 in the First Zinc Cluster of the Deoxyribonucleic Acid (DNA)-Binding Domain of the Androgen Receptor by Asp, Asn, or Leu Exerts Differential Effects on DNA Binding. , 1998, Endocrinology.

[20]  E. Kalkhoven,et al.  AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors , 1997, Molecular and cellular biology.

[21]  Hendrikus J Dubbink,et al.  The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. , 2004, Journal of structural biology.

[22]  O. Jänne,et al.  Androgen-receptor-interacting nuclear proteins. , 2000, Biochemical Society transactions.

[23]  F. S. French,et al.  Transcriptional activation and nuclear targeting signals of the human androgen receptor. , 1991, The Journal of biological chemistry.

[24]  O. Jänne,et al.  Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. , 2001, Molecular endocrinology.

[25]  E. Wilson,et al.  Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction* , 2002, The Journal of Biological Chemistry.

[26]  T. Willson,et al.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.

[27]  B. Katzenellenbogen,et al.  Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Chandra Verma,et al.  Dissecting the Vibrational Entropy Change on Protein/Ligand Binding: Burial of a Water Molecule in Bovine Pancreatic Trypsin Inhibitor , 2001 .

[29]  E. Wilson,et al.  Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs , 2003, Molecular and Cellular Biology.

[30]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[31]  Bruce A. Johnson,et al.  Both Coactivator LXXLL Motif-dependent and -independent Interactions Are Required for Peroxisome Proliferator-activated Receptor γ (PPARγ) Function* , 2000, The Journal of Biological Chemistry.

[32]  Millard H. Lambert,et al.  Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors , 2000 .

[33]  C. Heinlein,et al.  Androgen receptor (AR) coregulators: an overview. , 2002, Endocrine reviews.

[34]  J. Chen,et al.  The SRC family of nuclear receptor coactivators. , 2000, Gene.

[35]  M. Stallcup,et al.  Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. , 1998, Molecular Endocrinology.

[36]  A. Z. D. Ziel-van der Made,et al.  Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer , 2002, International journal of cancer.

[37]  O. Jänne,et al.  Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex* , 2002, The Journal of Biological Chemistry.

[38]  J. Trapman,et al.  Mechanisms of androgen receptor activation and function , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  Xiaodong Cheng,et al.  Synergy among Nuclear Receptor Coactivators: Selective Requirement for Protein Methyltransferase and Acetyltransferase Activities , 2002, Molecular and Cellular Biology.

[40]  O. Hiort,et al.  Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity. , 2000, The Journal of clinical endocrinology and metabolism.

[41]  D. Lawson,et al.  Structural origins of the interfacial activation in Thermomyces (Humicola) lanuginosa lipase. , 2000, Biochemistry.

[42]  T. Willson,et al.  Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition , 2002, Cell.

[43]  F. Claessens,et al.  The Androgen Receptor Amino-Terminal Domain Plays a Key Role in p160 Coactivator-Stimulated Gene Transcription , 1999, Molecular and Cellular Biology.

[44]  T. H. van der Kwast,et al.  Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. , 1991, Molecular endocrinology.

[45]  C. Glass,et al.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. , 1998, Genes & development.

[46]  David M. Heery,et al.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.

[47]  Howard M. Einspahr,et al.  Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  F. S. French,et al.  Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. , 1995, Molecular endocrinology.

[49]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[50]  D. Edwards,et al.  Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. , 1999, Molecular endocrinology.

[51]  F. Claessens,et al.  Dual Function of an Amino-terminal Amphipatic Helix in Androgen Receptor-mediated Transactivation through Specific and Nonspecific Response Elements* , 2003, The Journal of Biological Chemistry.

[52]  H. Gronemeyer,et al.  The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways , 1998, The EMBO journal.

[53]  J. A. Kemppainen,et al.  FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor* , 2000, The Journal of Biological Chemistry.

[54]  D. McDonnell,et al.  Evaluation of ligand-dependent changes in AR structure using peptide probes. , 2002, Molecular endocrinology.

[55]  E. Langley,et al.  Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer (*) , 1995, The Journal of Biological Chemistry.

[56]  M. Lambert,et al.  Activation of nuclear receptors: a perspective from structural genomics. , 2003, Structure.

[57]  J. Leers,et al.  Mechanistic Principles in NR Box-Dependent Interaction between Nuclear Hormone Receptors and the Coactivator TIF2 , 1998, Molecular and Cellular Biology.

[58]  M. Stallcup,et al.  GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R J Fletterick,et al.  Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.

[60]  J. Gustafsson,et al.  Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERα and ERβ* , 2001, The Journal of Biological Chemistry.

[61]  H. Gronemeyer,et al.  Activation Function 2 in the Human Androgen Receptor Ligand Binding Domain Mediates Interdomain Communication with the NH2-terminal Domain* , 1999, The Journal of Biological Chemistry.

[62]  Andrzej M. Brzozowski,et al.  Interaction of Transcriptional Intermediary Factor 2 Nuclear Receptor Box Peptides with the Coactivator Binding Site of Estrogen Receptor α* , 2002, The Journal of Biological Chemistry.